Paper
- Alzforum Recommends
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009 Apr;65(4):403-13. PubMed.
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ42 (CSF) |
AD (100) |
144 ± 41 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
Aβ42 (CSF) |
CTRL- CNC (114) |
206 ± 55 pg/mL |
xMAP; AlzBio3; Innogenetics |
|
tau-p181 (CSF) |
AD (100) |
42 ± 20 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
CTRL- CNC (114) |
25 ± 15 pg/mL |
xMAP; AlzBio3; Innogenetics |
|
tau-total (CSF) |
AD (100) |
122 ± 58 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- CNC (114) |
70 ± 30 pg/mL |
xMAP; AlzBio3; Innogenetics |
Please login to recommend the paper.
Comments